- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-05-0018263

Religence Pharmaceuticals Private Limited
About Religence Pharmaceuticals Private Limited
Data last updated:
Religence Pharmaceuticals Private Limited is a private limited company based in Bhavnagar, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2021PTC125905.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.43 Cr. It is led by directors including Chandrajitsinh Upendrasinh Chudasama and Mohit Bharatbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18/B Ajaywadi Subhashnagar, Bhavnagar, Gujarat, India – 364001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.8 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹94.13 Lakh and EBITDA of -₹23.76 Lakh.
As per MCA filings, the company has open charges of ₹6.77 Cr on record.
Religence Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-05-0018263). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Religence Pharmaceuticals
Contact details
Religence Pharmaceuticals Private Limited's registered office is in Bhavnagar, Gujarat.
- Registered Address18/B Ajaywadi Subhashnagar, Bhavnagar, Gujarat, India – 364001
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Religence Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Religence Pharmaceuticals Private Limited, buy the company report.
Financials of Religence Pharmaceuticals Private Limited
FY 2025 filings availableReligence Pharmaceuticals Private Limited reported revenue of ₹3.8 Lakh (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹23.76 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹94.13 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Religence Pharmaceuticals Private Limited, buy the company report.
Board of directors of Religence Pharmaceuticals Private Limited
Religence Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrajitsinh Upendrasinh Chudasama | Director | 20 Sep 2023 | 3 Years 1 Months | Current |
| Mohit Bharatbhai Patel | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Rupa Mohitbhai Patel | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Sachin Rasiklal Kalathiya | Director | 19 Jan 2024 | 2 Years 10 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Dec 2023 | 100828387 | State Bank of India | ₹6.77 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Religence Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Religence Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Religence Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Religence Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Sachin Rasiklal Kalathiya was appointed as Director on 19 Jan 2024.
Frequently asked questions
Religence Pharmaceuticals is an active private limited company based in Bhavnagar, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 27 September 2021 (5+ years old) and is registered under CIN U24230GJ2021PTC125905.
Religence Pharmaceuticals has 4 current directors:
- Chandrajitsinh Upendrasinh Chudasama - Director
- Mohit Bharatbhai Patel - Director
- Rupa Mohitbhai Patel - Director
- Sachin Rasiklal Kalathiya - Director
The latest financial statements of Religence Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Religence Pharmaceuticals is U24230GJ2021PTC125905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Religence Pharmaceuticals was incorporated on 27 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sachin Rasiklal Kalathiya was appointed as Director on 19 Jan 2024. Chandrajitsinh Upendrasinh Chudasama was appointed as Director on 20 Sep 2023. Mohit Bharatbhai Patel was appointed as Director on 27 Sep 2021. Religence Pharmaceuticals has 4 board changes on record in total.
Yes, Religence Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-05-0018263).
The registered office of Religence Pharmaceuticals is at 18B Ajaywadi Subhashnagar, Bhavnagar, Gujarat, India – 364001.
Religence Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.
Religence Pharmaceuticals has open charges of ₹6.77 Cr and no satisfied charges on record as per latest MCA filings.

